Impact Biomedical Inc. is an emerging human healthcare company and is a wholly owned subsidiary of DSS, Inc. The company is evaluating strategic options to accelerate value creation and has an existing collection of technology assets, distribution rights, and investments.
Impact Biomedical Inc. is a unique provider of natural and plant-based technology and business partner in addressing unmet needs in human healthcare and wellness.
Impact Biomedical develops valuable and unique patented technologies which could be licensed to pharmaceutical companies and venture capitalists in exchange for an agreed payment (fee or royalty). This interest will rise as the validating data becomes available.